FISH Vizgen Raises $37M in Series B Financing The Harvard spinout will use the proceeds to commercialize its Merscope technology for spatial transcriptomics and increase manufacturing capacity. Applied Spectral Imaging, Kromatid Ink Global Comarketing Pact for FISH Probes Through its Genasis imaging platform, ASI will also provide automation and image analysis capabilities to support the use of Kromatid's FISH probes. Spatial Omics Firms Use AGBT as Launchpad for New Tech Premium Vizgen, Rebus Biosystems, and Veranome Biosystems described their FISH-based platforms for spatial gene expression analysis for the first time. Spatial Biology Interest, Products Mushroomed in 2020 Premium New cellular and molecular spatial biology methods, companies, and product offerings have made this area one of the hottest in the life science market. Merus, Sema4 Partner to Accelerate Enrollment in Zenocutuzumab Trial Sema4 will use its next-generation sequencing testing services to identify patients with solid tumors harboring NRG1 fusions for Merus' Phase I/II drug trial. Dec 14, 2020 Startup Resolve Biosciences Readies Launch of Spatial Gene Expression Analysis Service Premium Sep 17, 2020 Adrenal Neuroblastoma Cell Features Found by Single-Cell Transcriptome Sequencing Jul 27, 2020 Vizgen Plans Launch of Spatial Transcriptomics Platform Based on MERFISH Technology Premium May 29, 2020 Tumor Microbiome Appears to Vary With Cancer Type May 26, 2020 Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer Apr 30, 2020 Treatment Clues Gleaned From Molecular Features in Rare Kidney Cancer Type Jan 30, 2020 Vizgen Launches With $14M Series A Financing Dec 10, 2019 KU-Led Team Begins Clinical Validation of Microfluidic Device for Leukemia MRD Detection Premium Oct 31, 2019 HER2 Amplification Confers Drug Sensitivity Across Tumor Types in New Study Premium Apr 22, 2019 Researchers Seek Best Approach to Identify Lung Cancer Patients With MET-Based Resistance Premium Mar 11, 2019 Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent Feb 21, 2019 Genome Organization Variation Uncovered With Molecular Mapping Methods Nov 13, 2018 Angle to Enter NIPT Market With Rare Cell Isolation Platform Premium Sep 26, 2018 Cancer Genetics, Agilent Sign FISH Probe Supply Deal Mar 9, 2018 Johns Hopkins flowFISH Cytometry Assay Predicts Risk of Genetic Diseases Premium Mar 2, 2018 Mosaic Maternal Fragile Site Expansion Adds to List of Variants Causing False-Positive NIPT Results Feb 6, 2018 Angle, Abbott Ink Deal for Use of FISH With Harvested CTCs Jan 24, 2018 Lung Cancer Molecular Testing Guidelines Updated by CAP, AMP, IASLC Jan 12, 2018 Molecular Analysis Offers Treatment Hints for Rare Nasal Cavity Cancer Sep 14, 2017 New Genetic Variant Discovered to Cause Peritoneal Mesothelioma Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.